Sean Lee
Stock Analyst at HC Wainwright & Co.
(3.63)
# 789
Out of 4,876 analysts
84
Total ratings
30.12%
Success rate
13.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SENS Senseonics Holdings | Assumes: Buy | $1.1 | $0.50 | +120.00% | 1 | Jun 2, 2025 | |
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $1.30 | +207.69% | 9 | May 19, 2025 | |
| CTSO Cytosorbents | Reiterates: Neutral | $1 | $1.15 | -13.04% | 13 | May 15, 2025 | |
| VSTM Verastem | Maintains: Buy | $10 → $14 | $4.16 | +236.54% | 14 | May 9, 2025 | |
| DWTX Dogwood Therapeutics | Upgrades: Buy | $10 | $4.77 | +109.64% | 1 | Apr 23, 2025 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $20 | $10.90 | +83.49% | 12 | Apr 14, 2025 | |
| MNPR Monopar Therapeutics | Reiterates: Buy | $40 | $35.01 | +14.25% | 10 | Apr 1, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $8 → $5.5 | $0.37 | +1,400.27% | 11 | Mar 28, 2025 | |
| CRVS Corvus Pharmaceuticals | Reiterates: Buy | $11 | $4.21 | +161.28% | 3 | Mar 26, 2025 | |
| MYO Myomo | Maintains: Buy | $7.5 → $9.5 | $2.22 | +327.93% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $6.53 | +1,431.39% | 4 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.17 | +2,464.10% | 1 | Dec 5, 2022 |
Senseonics Holdings
Jun 2, 2025
Assumes: Buy
Price Target: $1.1
Current: $0.50
Upside: +120.00%
CASI Pharmaceuticals
May 19, 2025
Reiterates: Buy
Price Target: $4
Current: $1.30
Upside: +207.69%
Cytosorbents
May 15, 2025
Reiterates: Neutral
Price Target: $1
Current: $1.15
Upside: -13.04%
Verastem
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $4.16
Upside: +236.54%
Dogwood Therapeutics
Apr 23, 2025
Upgrades: Buy
Price Target: $10
Current: $4.77
Upside: +109.64%
Alphatec Holdings
Apr 14, 2025
Reiterates: Buy
Price Target: $20
Current: $10.90
Upside: +83.49%
Monopar Therapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $35.01
Upside: +14.25%
Plus Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $8 → $5.5
Current: $0.37
Upside: +1,400.27%
Corvus Pharmaceuticals
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $4.21
Upside: +161.28%
Myomo
Mar 12, 2025
Maintains: Buy
Price Target: $7.5 → $9.5
Current: $2.22
Upside: +327.93%
Jul 12, 2024
Reiterates: Buy
Price Target: $100
Current: $6.53
Upside: +1,431.39%
Dec 5, 2022
Initiates: Buy
Price Target: $30
Current: $1.17
Upside: +2,464.10%